TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07070115: Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®

Sponsor: Tela Bio Inc · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 173 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$10,292,000

Rescue Site Savings

+$6,806,000

Unlock Full NCT07070115 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07070115 Rescue Dossier →